The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.

China imposed an import ban on Illumina’s gene sequencers in response to President Trump’s escalating tariffs and trade war ...

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory trade measures in response to the US doubling tariffs on all Chinese goods.

Shares in Chinese gene-sequencing companies surged on Tuesday after the announcement of the ban. MGI Tech led the gains, ...

Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...

Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...

Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...

Illumina (ILMN) is reducing its forecast for this year’s financial performance and cutting $100M in spending because China barred sales of its ...

Investing.com -- Chinese stocks related to genetic sequencing experienced gains after Beijing implemented a ban on the import of machines from Illumina (NASDAQ: ILMN ), a US-based company. This move ...

With most global sequencing done on Illumina’s machines, the company drives long-term profitability through scale and leadership in intellectual property. The strong integration of its solutions ...